论文部分内容阅读
目的:探讨三种含“参”类不同剂型中成药,如参芪胶囊、人参多糖针、参芪扶正注射液在临床上合理选用是否产生更好疗效。方法:对180例入组老弱或放化疗体虚患者,结合中医辨证和患者具体情况分为口服、肌注、静滴三小组,分别统计患者生存质量(KPS评分)、血色素水平、白细胞减少发生率及胃纳改善等情况,并与相同条件随机使用的180例比较分析。结果 :治疗组患者生存质量(KPS评分)84分、血色素水平106.80 g/L、胃纳改善比例151例(83.89%),均比对照组高;白细胞减少发生率32例(17.78%),比对照组低。结论:对同一类中成药采用中医辨证和结合患者具体情况选用口服、肌注、静滴剂型临床疗效更好,也更安全合理。
Objective: To investigate whether three kinds of traditional Chinese medicines with different dosage forms, such as Shenqi capsule, ginseng polysaccharide needles and Shenqi Fuzheng injection, have a better curative effect in clinic. Methods: One hundred and eighty patients were divided into three groups: oral administration, intramuscular injection and intravenous infusion. The KPS score, hemoglobin level, leukopenia Incidence and improvement of appetite and other conditions, and with the same conditions were used 180 cases of comparative analysis. Results: In the treatment group, the quality of life (KPS) was 84, the hemoglobin level was 106.80 g / L, and the appetite was improved in 151 cases (83.89%), which were higher than those in the control group. The incidence of leukopenia was 32 (17.78% The control group is low. Conclusion: The same type of proprietary Chinese medicine using traditional Chinese medicine syndrome differentiation and combined with the specific circumstances of patients with oral, intramuscular injection, intravenous infusion of clinical efficacy is better and more safe and reasonable.